Table 2.
Peptide | Sequence |
---|---|
Proopiomelanocortin products | |
β-Endorphin(1–27) | YGGFMTSEKSQTPLVL (10) |
β-Endorphin(1–31) | YGGFMTSEKSQTPLVL (14) |
Proenkephalin products | |
Leu-enkephalin | YGGFL |
Met-enkephalin | YGGFM |
Met-enkephalin-Arg-Phe | YGGFMRF |
Met-enkephalin-Arg-Gly-Leu | YGGFMRGL |
Metorphamide | YGGFMRRV-NH2 |
BAM 12 | YGGFMRRVGRPE |
BAM 18 | YGGFMRRVGRPEWW (4) |
BAM 22 | YGGFMRRVGRPEWW (7) |
Peptide E | YGGFMRRVGRPEWW (10) |
Prodynorphin products | |
Dynorphin A1–7 | YGGFLRR |
Dynorphin A1–8 | YGGFLRRI |
Dynorphin A1–9 | YGGFLRRIR |
Dynorphin A1–13 | YGGFLRRIRPKLK |
Dynorphin A1–17 | YGGFLRRIRPKLKWDNQ |
Dynorphin AB1–32 | YGGFLRRIRPKLKWD (17) |
Dynorphin B1–13 | YGGFLRRQFKVVT |
Leumorphin | YGGFLRRQFKVVTR (15) |
α-Neo-endorphin | YGGFLRKYPK |
β-Neo-endorphin | YGGFLRKYP |
Amino acid sequences of peptides derived from the opioid precursor proteins proopiomelanocortin, proenkephalin, and prodynorphin, using the single letter amino acid notation. Where only a partial sequence is given, the number of additional amino acids is indicated in parentheses.